BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11035112)

  • 1. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice.
    Noorchashm H; Moore DJ; Noto LE; Noorchashm N; Reed AJ; Reed AL; Song HK; Mozaffari R; Jevnikar AM; Barker CF; Naji A
    J Immunol; 2000 Oct; 165(8):4685-96. PubMed ID: 11035112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice.
    Greeley SA; Moore DJ; Noorchashm H; Noto LE; Rostami SY; Schlachterman A; Song HK; Koeberlein B; Barker CF; Naji A
    J Immunol; 2001 Oct; 167(8):4351-7. PubMed ID: 11591759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background.
    Koarada S; Wu Y; Olshansky G; Ridgway WM
    J Immunol; 2002 Dec; 169(11):6580-7. PubMed ID: 12444170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice.
    Arreaza G; Salojin K; Yang W; Zhang J; Gill B; Mi QS; Gao JX; Meagher C; Cameron M; Delovitch TL
    Clin Immunol; 2003 May; 107(2):103-15. PubMed ID: 12763479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors.
    Jang MH; Seth NP; Wucherpfennig KW
    J Immunol; 2003 Oct; 171(8):4175-86. PubMed ID: 14530340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages.
    Sen P; Bhattacharyya S; Wallet M; Wong CP; Poligone B; Sen M; Baldwin AS; Tisch R
    J Immunol; 2003 Feb; 170(4):1770-80. PubMed ID: 12574341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of T and B lymphocyte activation in nonobese diabetic mice.
    Chiu PP; Jevnikar AM; Danska JS
    J Immunol; 2001 Dec; 167(12):7169-79. PubMed ID: 11739540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idd9/11 genetic locus regulates diabetogenic activity of CD4 T-cells in nonobese diabetic (NOD) mice.
    Chen YG; Scheuplein F; Osborne MA; Tsaih SW; Chapman HD; Serreze DV
    Diabetes; 2008 Dec; 57(12):3273-80. PubMed ID: 18776136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
    Mora C; Wong FS; Chang CH; Flavell RA
    J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice.
    Silveira PA; Dombrowsky J; Johnson E; Chapman HD; Nemazee D; Serreze DV
    J Immunol; 2004 Apr; 172(8):5086-94. PubMed ID: 15067092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
    Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
    J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
    Koarada S; Wu Y; Ridgway WM
    J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.
    Ridgway WM; Ito H; Fassò M; Yu C; Fathman CG
    J Exp Med; 1998 Dec; 188(12):2267-75. PubMed ID: 9858513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
    Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
    J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.